Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
25 participants
OBSERVATIONAL
2025-12-01
2026-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Exercise With Visual Feedback in Parkinson's Disease
NCT07322939
Validity and Reliability of the Standing Up From Supine Test With Parkinson's Patients
NCT06859385
Effect of Dual Task on Upper and Lower Extremity Skills in Parkinson's Disease
NCT04267341
The Reliability, Validity, and Responsiveness of the Timed 360° Turn Test in Patients With Parkinson's Disease
NCT03587168
The Relationship of Trunk Position Sense and Spinal Posture With Balance in Parkinson's
NCT05233943
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Two independent raters will perform GYKO-based assessments of the L-Test and TUG on the same day, with a 20-minute interval between raters, to determine interrater reliability. Participants will return one week later to repeat the same procedures, allowing assessment of test-retest reliability.
To examine concurrent validity, participants' functional balance will also be assessed using the Berg Balance Scale, and correlations between GYKO variables and clinical mobility tests (L-Test and TUG) will be analyzed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parkinson's disease group
Parkinson's disease patients with stage 1-3 hoehn yahr
GYKO-Based Postural Sway Assessment
This procedure involves obtaining postural sway parameters using the GYKO inertial measurement device during the Time Up and Go (TUG) test and L-Test. No therapeutic intervention is applied.
Time Up and Go Test: Timed Up and Go (TUG) is a standardized functional mobility test used to assess dynamic balance and gait performance. Participants are instructed to stand up from a standard-height chair, walk 3 meters, turn around, walk back to the chair, and sit down. The total time to complete the task (in seconds) is recorded. Higher times indicate reduced mobility.
L Test: Time (in seconds) to complete the L-Test of Functional Mobility. The test requires participants to stand up from a chair, walk 3 m, execute a 90° turn, walk another 7 m, perform a 180° turn, and return along the same path (total walking distance ≈ 20 m). The task ends when the participant sits back down. The total time to complete the task (in seconds) is recorded. Higher times indicate reduced mobility.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GYKO-Based Postural Sway Assessment
This procedure involves obtaining postural sway parameters using the GYKO inertial measurement device during the Time Up and Go (TUG) test and L-Test. No therapeutic intervention is applied.
Time Up and Go Test: Timed Up and Go (TUG) is a standardized functional mobility test used to assess dynamic balance and gait performance. Participants are instructed to stand up from a standard-height chair, walk 3 meters, turn around, walk back to the chair, and sit down. The total time to complete the task (in seconds) is recorded. Higher times indicate reduced mobility.
L Test: Time (in seconds) to complete the L-Test of Functional Mobility. The test requires participants to stand up from a chair, walk 3 m, execute a 90° turn, walk another 7 m, perform a 180° turn, and return along the same path (total walking distance ≈ 20 m). The task ends when the participant sits back down. The total time to complete the task (in seconds) is recorded. Higher times indicate reduced mobility.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hoehn \& Yahr stage 1-3
* Ability to walk independently with or without an assistive device
* Ability to follow verbal instructions
* Age 50-85
Exclusion Criteria
* Deep brain stimulation (DBS) implant
* Severe visual or auditory impairment
50 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hasan Kalyoncu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Büşra Akıncı
MSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Büşra Akıncı, MSc
Role: STUDY_CHAIR
Hasan Kalyonuc University
Günseli Usgu, Assoc. Prof.
Role: STUDY_DIRECTOR
Hasan Kalyoncu University
Saadet Nur Çörekçioğlu, P.T.
Role: PRINCIPAL_INVESTIGATOR
Hasan Kalyoncu University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hasan Kalyoncu University
Gaziantep, Şahinbey, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Haas B, Clarke E, Elver L, Gowman E, Mortimer E, Byrd E. The reliability and validity of the L-test in people with Parkinson's disease. Physiotherapy. 2019 Mar;105(1):84-89. doi: 10.1016/j.physio.2017.11.218. Epub 2017 Dec 5.
Zampieri C, Salarian A, Carlson-Kuhta P, Aminian K, Nutt JG, Horak FB. The instrumented timed up and go test: potential outcome measure for disease modifying therapies in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2010 Feb;81(2):171-6. doi: 10.1136/jnnp.2009.173740. Epub 2009 Sep 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HKU/PH/2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.